PROTACs Research

PROTACs (PROteolysis TArgeting Chimeras) are heterobifunctional small molecules containing binding moieties for an E3 ubiquitin ligase and a target protein joined by a linker. PROTACs induce targeted protein degradation via the Ubiquitin Proteasome System. Tocris has a range of active PROTACs targeting different proteins, as well as a toolbox of PROTAC building blocks to support PROTAC research and development.

Our sister Bio-Techne brands offer a range of E3 ligase enzymes, custom E3 ligase enzyme production, as well as assays and kits for ubiquitin research and proteomic analysis of ubiquitination.

Are you developing PROTACs in your lab? For quantitative, reproducible and automated analysis of protein degradation, check out the Simple Western™ range from our sister brand, Protein Simple.

Targets
Literature

PROTACs - Tools for Targeted Protein Degradation

PROTACs - Tools for Targeted Protein Degradation

Figure 1: Schematic showing PROTACs catalytic mode of action. PROTACs initiate the formation of a ternary complex between an E3 ubiquitin ligase and a target protein which results in polyubiquitination of the target protein, its recognition by the proteasome and subsequent degradation. PROTACs act catalytically by repeatedly engaging and directing the ubiquitination of target molecules.

Adapted from Tinworth et al. (2016) Med.Chem.Comm. 7 2206.


PROTACs (PROteolysis TArgeting Chimeras) are heterobifunctional small molecules, around 700-1000 Da in size, which induce targeted protein degradation (TPD) via the Ubiquitin Proteasome System (UPS). The UPS initiates protein degradation via the addition of ubiquitin to substrate proteins, a process performed by E3 ligases.

PROTACs consist of binding moieties for an E3 ubiquitin ligase and a target protein joined by a linker. The binding of both moieties results in the formation of a ternary complex between target protein and E3 ligase, leading to polyubiquitination of the target protein, its recognition by the proteasome and subsequent degradation.

A key feature of PROTACs is their catalytic mode of action. They dissociate following ubiquitination and rebind to new target proteins, which allows their use at sub-stoichiometric concentrations.

PROTACs represent an exciting new modality, repurposing small molecule chemical tools to selectively degrade, rather than simply inhibit, target proteins of interest.

Literature for PROTACs Research

Tocris offers the following scientific literature for PROTACs Research to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cancer

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis